Generics
Total Trials
4
As Lead Sponsor
2
As Collaborator
Total Enrollment
362
NCT04407208
Convalescent Plasma Therapy in Patients With COVID-19
Phase: Phase 1
Role: Lead Sponsor
Start: May 1, 2020
Completion: Jun 22, 2020
NCT04788355
Prevention of Complications (SARS-CoV-2): Clinical Study
Phase: Phase 3
Role: Collaborator
Start: Jul 1, 2020
Completion: Dec 23, 2020
NCT06252051
Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)
Phase: Phase 4
Start: Jan 5, 2021
Completion: Aug 31, 2022
NCT06283784
Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients
Phase: N/A
Start: Sep 5, 2021
Completion: May 18, 2022
Loading map...